SPARCBSESun Pharma Advanced Research Company Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Wed, 20 May, 2026 · 17:18 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanghvi Finance Pvt Ltd & PACs

Creeping Acquisition Near ThresholdPromoter Stake BuyOwnership Changes View source PDFExplain this filing

SPARC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.6%Reaction day
₹183.00
prior close
₹185.00
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+1.1%-2.7% vs market
Pharmaceuticals peers, median of 160sector+0.2%-1.8% vs sector

On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
-0.4
15m
-1.0
30m
+1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.6+1.1-2.7+0.2-1.8
Next day
+16.4+1.2+15.2+0.1+16.3
2d
+28.9+2.8+26.1+1.4+27.4
3d
+26.9+3.5+23.3+1.3+25.5
4d
+21.7+3.5+18.2+1.6+20.1
5d
+15.7+2.8+12.8+1.0+14.7
1w
+11.5+2.8+8.7+0.2+11.2
15d
+22.7+4.2+18.5+0.5+22.2
1m
+29.9+10.1+19.8+2.8+27.1
2m
+22.9+10.0+12.9+6.9+16.0
3m
+7.5+14.6-7.1+8.2-0.7
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shanghvi Finance Private Limited, along with 13 Persons Acting in Concert (PACs) including promoter Dilip S. Shanghvi and family members, received 3,85,10,000 convertible warrants via preferential allotment. Each warrant converts to 1 equity share at ₹155.80, with total consideration of approximately ₹600 crore on full conversion. Before this acquisition, the promoter group held 21,13,15,095 shares (65.67%). After acquisition, Shanghvi Finance's direct holding remains 42.28% of equity capital, but the warrants add 10.61% on diluted basis. The warrants carry no voting rights until conversion, which must occur within 18 months.

Likely market impact

Promoter group is consolidating further control by acquiring warrants that could increase their total holding to 69.31% on fully diluted basis. This represents a creeping acquisition by the promoter group, though no immediate change in voting rights occurs as warrants are not yet converted.